Related Experiment Videos
[Surgically assisted rapid maxillary expansion: a retrospective study]
F Bierenbroodspot1, P C Wering, A M Kuijpers-Jagtman
1Afdeling Mond- en Kaakchirurgie, Universitair Medisch Centrum Sint Radboud, Huispost 421 Postbus 9101, 6500 HB Nijmegen.
Nederlands Tijdschrift Voor Tandheelkunde
|September 6, 2002
Summary
Surgically Assisted Rapid Maxillary Expansion (SARME) effectively corrects transverse maxillary hypoplasia in adults and adolescents. This study shows SARME provides predictable and stable maxillary expansion with satisfactory outcomes in seven patients.
Area of Science:
- Orthodontics
- Oral and Maxillofacial Surgery
Context:
- Transverse maxillary hypoplasia is a common condition affecting adolescents and adults.
- Surgically Assisted Rapid Maxillary Expansion (SARME) is a surgical-orthodontic procedure used to correct this.
- Limited data exists on the long-term stability and predictability of SARME.
Purpose:
- To evaluate the effectiveness and stability of SARME in treating transverse maxillary hypoplasia.
- To present the results of seven patients treated with SARME.
- To analyze the technique, expansion type, and long-term stability (1-1.5 years post-procedure).
Summary:
- Seven patients with transverse maxillary hypoplasia underwent SARME.
- Mean maxillary expansion was 4.7 mm between cuspids and 5.6 mm between first molars.
- The procedure demonstrated predictable results and sufficient expansion with stable outcomes.
Impact:
- SARME offers a predictable and effective solution for correcting transverse maxillary hypoplasia.
- The technique provides satisfactory results with no reported complications in this patient cohort.
- This study contributes to understanding SARME's efficacy and stability in orthodontic treatment planning.